Search research articles
Contact Us
Filters
Showing results (61-70 of 156) with videos related to
Page
of 16
Sort By:
Journal of Clinical Pharmacology
|
October 1, 2010
Fostering culture and optimizing organizational structure for implementing model-based drug development
Liping Zhang, Sandra R Allerheiligen, Richard L Lalonde, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
December 16, 2016
Characterizing the dynamic interaction among gastric emptying, glucose absorption, and glycemic control in nondiabetic obese adults
Mélanie Wilbaux, Bettina K Wölnerhanssen, Anne Christin Meyer-Gerspach, et al.
Clinical Pharmacology and Therapeutics
|
January 14, 2020
Pharmacometrics and Machine Learning Partner to Advance Clinical Data Analysis
Gilbert Koch, Marc Pfister, Imant Daunhawer, et al.
Frontiers in Digital Health
|
March 5, 2025
Assessing accuracy of BiliPredics algorithm in predicting individual bilirubin progression in neonates-results from a prospective multi-center study
Britta Steffens, Gilbert Koch, Corinna Engel, et al.
Journal of Clinical Pharmacology
|
May 16, 2024
Applying Neural ODEs to Derive a Mechanism-Based Model for Characterizing Maturation-Related Serum Creatinine Dynamics in Preterm Newborns
Dominic Stefan Bräm, Gilbert Koch, Karel Allegaert, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
January 29, 2016
Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period
Janko Samardzic, Karel Allegaert, Mélanie Wilbaux, et al.
Journal of Clinical Pharmacology
|
September 11, 2019
Age-Dependent Changes of Kidney Injury Biomarkers in Pediatrics
Tamara van Donge, Tatjana Welzel, Andrew Atkinson, et al.
Clinical Pharmacology and Therapeutics
|
April 18, 2019
Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and Adults
Janneke M Brussee, Jessica D Schulz, Jean T Coulibaly, et al.
Clinical Therapeutics
|
October 28, 2011
Influence of hepatic impairment on the pharmacokinetics and safety profile of dapagliflozin: an open-label, parallel-group, single-dose study
Sreeneeranj Kasichayanula, Xiaoni Liu, Weijiang Zhang, et al.
Therapeutics and Clinical Risk Management
|
June 22, 2011
Quantifying the impact of nonadherence patterns on exposure to oral immunosuppressants
J Ross Maclean, Marc Pfister, Zexun Zhou, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 156) with videos related to
Sort By:
Page
of 16
Journal of Clinical Pharmacology
|
October 1, 2010
Fostering culture and optimizing organizational structure for implementing model-based drug development
Liping Zhang, Sandra R Allerheiligen, Richard L Lalonde, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
December 16, 2016
Characterizing the dynamic interaction among gastric emptying, glucose absorption, and glycemic control in nondiabetic obese adults
Mélanie Wilbaux, Bettina K Wölnerhanssen, Anne Christin Meyer-Gerspach, et al.
Clinical Pharmacology and Therapeutics
|
January 14, 2020
Pharmacometrics and Machine Learning Partner to Advance Clinical Data Analysis
Gilbert Koch, Marc Pfister, Imant Daunhawer, et al.
Frontiers in Digital Health
|
March 5, 2025
Assessing accuracy of BiliPredics algorithm in predicting individual bilirubin progression in neonates-results from a prospective multi-center study
Britta Steffens, Gilbert Koch, Corinna Engel, et al.
Journal of Clinical Pharmacology
|
May 16, 2024
Applying Neural ODEs to Derive a Mechanism-Based Model for Characterizing Maturation-Related Serum Creatinine Dynamics in Preterm Newborns
Dominic Stefan Bräm, Gilbert Koch, Karel Allegaert, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
January 29, 2016
Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period
Janko Samardzic, Karel Allegaert, Mélanie Wilbaux, et al.
Journal of Clinical Pharmacology
|
September 11, 2019
Age-Dependent Changes of Kidney Injury Biomarkers in Pediatrics
Tamara van Donge, Tatjana Welzel, Andrew Atkinson, et al.
Clinical Pharmacology and Therapeutics
|
April 18, 2019
Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and Adults
Janneke M Brussee, Jessica D Schulz, Jean T Coulibaly, et al.
Clinical Therapeutics
|
October 28, 2011
Influence of hepatic impairment on the pharmacokinetics and safety profile of dapagliflozin: an open-label, parallel-group, single-dose study
Sreeneeranj Kasichayanula, Xiaoni Liu, Weijiang Zhang, et al.
Therapeutics and Clinical Risk Management
|
June 22, 2011
Quantifying the impact of nonadherence patterns on exposure to oral immunosuppressants
J Ross Maclean, Marc Pfister, Zexun Zhou, et al.
Page
of 16